Lymphoma, Mantle-Cell  >>  Zejula (niraparib)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zejula (niraparib) / GSK, J&J
NCT01244009: A Study of MK-4827 for the Treatment of Mantle Cell Lymphoma (MK-4827-002)

Withdrawn
2
0
US
MK-4827
Tesaro, Inc.
Lymphoma, Mantle-Cell
08/13
08/13

Download Options